Back to search results

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

Abroad (travel likely)Recruiting

Conditions

AL Amyloidosis · Smoldering Multiple Myeloma · Monoclonal Gammopathy of Undetermined Significance

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Azienda Ospedaliera Policlinico Consorziale, Bari, Italy

    Contact: Study coordinator (PELLEGRINO MUSTO, MD) · ematologiacontrapianto@policlinico.ba.it · 080 5593471
    Contact: Principal Investigator (PELLEGRINO MUSTO, MD)
    Angela Minervini, MD, PhD (Sub-investigator)

  • Azienda Ospedaliero Universitaria Policlinico G.Rodolico - San Marco, Catania, Italy

    Contact: Study coordinator (Francesco Di Raimondo, MD) · segremat@unict.it · 095/378.1956
    Contact: Principal Investigator (Francesco Di Raimondo, MD)
    Concetta Maria Sebastiana Conticello, MD, PhD (Sub-investigator)

  • Fondazione Irccs Policlinico San Matteo, Pavia, Italy

    Contact: Study coordinator (GIOVANNI PALLADINI, MD, PhD) · segreteria.amiloidosi@smatteo.pv.it · +390382502994
    Contact: Principal Investigator (GIOVANNI PALLADINI, MD, PhD)
    Contact: Principal Investigator (Luca Arcaini, MD)
    Mario Ulisse Nuvolone, MD, PhD (Sub-investigator)

  • EMATOLOGIA - Città della Scienza e Salute - Torino, Torino, Italy

    Contact: Study coordinator (FRANCESCA MARIA GAY, MD, PhD) · ematologia@cittadellasalute.to.it · 011.633.5550 - 5935
    Contact: Principal Investigator (FRANCESCA MARIA GAY, MD, PhD)
    Stefania Oliva, MD, PhD (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)